Thakur, R.; Bhatia, P.; Singh, M.; Sreedharanunni, S.; Sharma, P.; Singh, A.; Trehan, A.
Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Diagnostics 2023, 13, 884.
https://doi.org/10.3390/diagnostics13050884
AMA Style
Thakur R, Bhatia P, Singh M, Sreedharanunni S, Sharma P, Singh A, Trehan A.
Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Diagnostics. 2023; 13(5):884.
https://doi.org/10.3390/diagnostics13050884
Chicago/Turabian Style
Thakur, Rozy, Prateek Bhatia, Minu Singh, Sreejesh Sreedharanunni, Pankaj Sharma, Aditya Singh, and Amita Trehan.
2023. "Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia" Diagnostics 13, no. 5: 884.
https://doi.org/10.3390/diagnostics13050884
APA Style
Thakur, R., Bhatia, P., Singh, M., Sreedharanunni, S., Sharma, P., Singh, A., & Trehan, A.
(2023). Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Diagnostics, 13(5), 884.
https://doi.org/10.3390/diagnostics13050884